MedTrace Logo

Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients

NCT05900635 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-06-12

No results posted yet for this study

Summary

The aim of this study is to evaluate the effects of adding lactoferrin to the every-other-day oral iron supplementation in iron deficiency anemia and chronic kidney disease patients.

Conditions

  • Anemia of Chronic Kidney Disease

Interventions

DRUG

Lactoferrin

Effect of adding Lactoferrin to Oral Iron Supplementation for the treatment of Iron Deficiency Anemia in Chronic Kidney Disease Patients

DRUG

Ferrous Glycine Sulfate

Effect of adding Lactoferrin to Oral Iron Supplementation for the treatment of Iron Deficiency Anemia in Chronic Kidney Disease Patients

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Ahmed F Elkoraie, Prof · Alexandria University

  • Magda A Elmassik, Prof · Alexandria University

  • Noha A Hamdy, PhD · Alexandria University

  • Engy M Emam, PharmD · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-06-30
Completion
2023-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05900635 on ClinicalTrials.gov